996
Views
8
CrossRef citations to date
0
Altmetric
Clinical features - Review

Relapsing polychondritis: state-of-the-art review with three case presentations

, , , &
Pages 953-963 | Received 12 May 2021, Accepted 24 Aug 2021, Published online: 30 Sep 2021

References

  • Polychondropathia J-WR. Wien Arch F Inn Med. 1923;6:93–100.
  • Butterton JR, Collier DS, Romero JM, et al. Case records of the Massachusetts General Hospital. Case 14-2007. A 59-year-old man with fever and pain and swelling of both eyes and the right ear. N Engl J Med. 2007;356(19):1980–1988.
  • Sharma A, Gnanapandithan K, Sharma K, et al. Relapsing polychondritis: a review. Clin Rheumatol. 2013;32(11):1575–1583.
  • Kent PD, Michet CJ, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. 2004;16(1):56–61.
  • Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol. 2006;24(6):482–485.
  • Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med. 1998;129(2):114–122.
  • Arnaud L, Devilliers H, Peng SL, et al. The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev. 2012;12(2):204–209.
  • Cuestas D, Peñaranda E, Mora S, et al. Relapsing polychondritis, an underestimated dermatological urgency: case report and literature review. Int J Dermatol. 2017;56(12):1379–1386.
  • Moulis G, Pugnet G, Costedoat-Chalumeau N, et al. Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study. Ann Rheum Dis. 2018;77(8):1172–1178.
  • Mathew SD, Battafarano DF, Morris MJ. Relapsing Polychondritis in the Department of Defense Population and Review of the Literature. Semin Arthritis Rheum. 2012;42(1):70–83.
  • Papo T, Wechsler B, Bletry O, et al. Pregnancy in relapsing polychondritis: twenty-five pregnancies in eleven patients. Arthritis Rheum. 1997;40(7):1245–1249.
  • Haslag-Minoff J, Relapsing Polychondritis RH. N Engl J Med. 2018;378(18):1715.
  • Paravar T. Less common rheumatologic disorders: current concepts of skin and systemic manifestations. Clin Dermatol. 2018;36(4):525–532.
  • Krishnan Y, Grodzinsky AJ. Cartilage diseases. Matrix Biol J Int Soc Matrix Biol. 2018;71-72:51–69.
  • Lang B, Rothenfusser A, Lanchbury JS, et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 1993;36(5):660–664.
  • Alsalameh S, Mollenhauer J, Scheuplein F, et al. Preferential cellular and humoral immune reactivities to native and denatured collagen types IX and XI in a patient with fatal relapsing polychondritis. J Rheumatol. 1993;20(8):1419–1424.
  • Stabler T, Piette J-C, Chevalier X, et al. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum. 2004;50(11):3663–3667.
  • Yang CL, Brinckmann J, Rui HF, et al. Autoantibodies to cartilage collagens in relapsing polychondritis. Arch Dermatol Res. 1993;285(5):245–249.
  • Hansson AS, Heinegård D, Holmdahl R. A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest. 1999;104(5):589–598.
  • Hansson AS, Heinegård D, Piette JC, et al. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum. 2001;44(10):2402–2412.
  • Foidart JM, Abe S, Martin GR, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978;299(22):1203–1207.
  • Bergfeld WF. Relapsing polychondritis with positive direct immunofluorescence. Arch Dermatol. 1978;114(1):127.
  • Bachor E, Blevins NH, Karmody C, et al. Otologic manifestations of relapsing polychondritis. Review of literature and report of nine cases. Auris Nasus Larynx. 2006;33(2):135–141.
  • Smylie A, Malhotra N, Relapsing Polychondritis: BA, et al. Guide for the Dermatologist. Am J Clin Dermatol. 2017;18(1):77–86.
  • Michet CJ, McKenna CH, Luthra HS, et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104(1):74–78.
  • Puéchal X, Terrier B, Mouthon L, et al. Relapsing polychondritis. Joint Bone Spine. 2014;81(2):118–124.
  • Kingdon J, Roscamp J, Sangle S, et al. Relapsing polychondritis: a clinical review for rheumatologists. Rheumatol Oxf Engl. 2018;57(9):1525–1532.
  • Borgia F, Giuffrida R, Guarneri F, et al. Relapsing Polychondritis: an Updated Review. Biomedicines. 2018;6:3.
  • Gergely P, Poór G. Relapsing polychondritis. Best Pract Res Clin Rheumatol. 2004;18(5):723–738.
  • Rarediseases. Relapsing polychondritis | genetic and Rare Diseases Information Center (GARD) – an NCATS Program. 2021 Apr 11. https://rarediseases.info.nih.gov/diseases/7417/relapsing-polychondritis
  • Ontology HP. Human Phenotype Ontology. Apr 11, 2021. https://hpo.jax.org/app/browse/disease/ORPHA:728
  • Letko E, Zafirakis P, Baltatzis S, et al. Relapsing polychondritis: a clinical review. Semin Arthritis Rheum. 2002;31(6):384–395.
  • Isaak BL, Liesegang TJ, Michet CJ. Ocular and systemic findings in relapsing polychondritis. Ophthalmology. 1986;93(5):681–689.
  • Yu EN, Jurkunas U, Rubin PAD, et al. Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis. Cornea. 2006;25(5):621–622.
  • Lahmer T, Treiber M, von Werder A, et al. Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev. 2010;9(8):540–546.
  • McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55(3):193–215.
  • Rafeq S, Trentham D, Ernst A. Pulmonary manifestations of relapsing polychondritis. Clin Chest Med. 2010;31(3):513–518.
  • Del Rosso A, Petix NR, Pratesi M, et al. Cardiovascular involvement in relapsing polychondritis. Semin Arthritis Rheum. 1997;26(6):840–844.
  • Lang-Lazdunski L, Hvass U, Paillole C, et al. Cardiac valve replacement in relapsing polychondritis. A review. J Heart Valve Dis. 1995;4(3):227–235.
  • Esdaile J, Hawkins D, Gold P, et al. Vascular involvement in relapsing polychondritis. Can Med Assoc J. 1977;116(9):1019–1022.
  • Firestein GS, Gruber HE, Weisman MH, et al. Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet’s disease. Am J Med. 1985;79(1):65–72.
  • Jeon CH. Relapsing Polychondritis with Central Nervous System Involvement: experience of Three Different Cases in a Single Center. J Korean Med Sci. 2016;31(11):1846–1850.
  • Erten-Lyons D, Oken B, Woltjer RL, et al. Relapsing polychondritis: an uncommon cause of dementia. J Neurol Neurosurg Psychiatry. 2008;79(5):609–610.
  • Ellis RJB, Mbizvo GK, Jacob A, et al. Relapsing polychondritis complicated by cognitive dysfunction: two distinct clinical phenotypes? Int J Neurosci. 2017;127(2):124–134.
  • Chang-Miller A, Okamura M, Torres VE, et al. Renal involvement in relapsing polychondritis. Medicine (Baltimore). 1987;66(3):202–217.
  • Zeng Y, Li M, Chen S, et al. Is 18F-FDG PET/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy? Arthritis Res Ther. 2019;21(1):282.
  • Damiani JM, Levine HL Relapsing polychondritis — REPORT OF TEN CASES. The Laryngoscope. 1979;89( 6):929–946.
  • Lee KS, Ernst A, Trentham DE, et al. Relapsing polychondritis: prevalence of expiratory CT airway abnormalities. Radiology. 2006;240(2):565–573.
  • Thaiss WM, Nikolaou K, Spengler W, et al. Imaging diagnosis in relapsing polychondritis and correlation with clinical and serological data. Skeletal Radiol. 2016;45(3):339–346.
  • Matsushita S, Matsuoka S, Yamashiro T, et al. Quantitative Computed Tomography Assessment of Air Trapping in Relapsing Polychondritis: correlations With Spirometric Values. J Comput Assist Tomogr. 2014;38(6):968–971.
  • Sharma A, Kumar R, Mb A, et al. Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis. Rheumatology. 2020;59(1):99–106.
  • Wang J, Li S, Zeng Y, et al. 18F-FDG PET/CT is a valuable tool for relapsing polychondritis diagnose and therapeutic response monitoring. Ann Nucl Med. 2014;28(3):276–284.
  • Lei W, Zeng H, Zeng D, et al. 18F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis. Br J Radiol. 2016;89:1057.
  • Lei W, Zeng D-X, Chen T, et al. FDG PET-CT combined with TBNA for the diagnosis of atypical relapsing polychondritis: report of 2 cases and a literature review. J Thorac Dis. 2014;6(9).
  • Chang M-C, Tsai S-C, Lin W-Y. Value of gallium-67 scanning in monitoring therapeutic effectiveness in a patient with relapsing polychondritis. Kaohsiung J Med Sci. 2008;24(6):328–333.
  • Güngör F, Ozdemir T, Tunçdemir F, et al. Tc-99m MDP bone scintigraphy in relapsing polychondritis. Clin Nucl Med. 1997;22(4):264–266.
  • Vitale A, Sota J, Rigante D, et al. Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives. Curr Rheumatol Rep. 2016;18(1):3.
  • Miyazu Y, Miyazawa T, Kurimoto N, et al. Endobronchial Ultrasonography in the Diagnosis and Treatment of Relapsing Polychondritis With Tracheobronchial Malacia. CHEST. 2003;124(6):2393–2395.
  • Hojaili B, Keiser HD. Relapsing polychondritis presenting with complete heart block. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2008;14(1):24–26.
  • Dib C, Moustafa SE, Mookadam M, et al. Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin Proc. 2006;81(6):772–776.
  • Yoo JH, Chodosh J, Dana R. Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management, and prognosis. Semin Ophthalmol. 2011;26(4–5):261–269.
  • Earwood JS, Rogers TS, Rathjen NA, Ear Pain: diagnosing Common and Uncommon Causes. Am Fam Physician. 2018;97(1):20–27. Accessed 2021 Apr 11 https://www.aafp.org/afp/2018/0101/p20.html.
  • Dion J, Costedoat-Chalumeau N, Sène D, et al. Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: analysis of a Recent Series of 142 Patients. Arthritis Rheumatol Hoboken NJ. 2016;68(12):2992–3001.
  • Masiak A, Zdrojewski Z, Pęksa R, et al. The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Reumatologia/Rheumatology. 2017;55(5):230–236.
  • Rednic S, Damian L, Talarico R, et al. Relapsing polychondritis: state of the art on clinical practice guidelines. RMD Open. 2018;4(Suppl 1):e000788.
  • Abdel Razek AAK. Imaging of connective tissue diseases of the head and neck. Neuroradiol J. 2016;29(3):222–230.
  • strowski RA, Takagishi T, Robinson J. Chapter 29 - Rheumatoid arthritis, spondyloarthropathies, and relapsing polychondritis. In: Biller J, Ferro JM, eds. Handbook of Clinical Neurology. Vol 119. Neurologic Aspects of Systemic Disease Part I. Elsevier; 2014:449–461. doi:https://doi.org/10.1016/B978-0-7020-4086-3.00029-1
  • Hebbar M, Brouillard M, Wattel E, et al. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia. 1995;9(4):731–733.
  • Schumacher S, Pieringer H. Relapsing polychondritis: a chameleon among orphan diseases. Wien Med Wochenschr. 2017;167(9):227–233.
  • Mark KA, Franks AG. Colchicine and indomethacin for the treatment of relapsing polychondritis. J Am Acad Dermatol. 2002;46(2):S22–24. Suppl Case Reports)
  • Mathian A, Miyara M, Cohen-Aubart F, et al. Relapsing polychondritis: a 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol. 2016;30(2):316–333.
  • Sosada B, Loza K, Relapsing Polychondritis B-WE. Case Rep Dermatol Med. 2014;2014;e791951. https://doi.org/10.1155/2014/791951.
  • Hazra N, Dregan A, Charlton J, et al. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology. 2015;54(12):2181–2187.
  • Martin J, Roenigk HH, Lynch W, et al. Relapsing polychondritis treated with dapsone. Arch Dermatol. 1976;112(9):1272–1274.
  • Dalal BI, Wallace AC, Slinger RP. IgA nephropathy in relapsing polychondritis. Pathology. 1988;20(1):85–89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.